Related Experiment Video

Updated: Jun 11, 2026

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations
05:04

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations

Published on: February 2, 2024

Advances in pediatric restless legs syndrome: Iron, genetics, diagnosis and treatment

Matthew A Picchietti1, Daniel L Picchietti

  • 1Department of Psychology, Southern Illinois University, Carbondale, IL 62901, USA. picchima@siu.edu

Sleep Medicine
|July 13, 2010
PubMed

Insights

Pediatric restless legs syndrome (RLS) affects 1.9% of children and adolescents. Research highlights iron therapy benefits and genetic links, but more rigorous studies are needed for effective treatment.

Area of Science:

  • Pediatric Neurology
  • Sleep Medicine
  • Genetics

Background:

  • Pediatric restless legs syndrome (RLS) affects approximately 1.9% of individuals aged 8–18 years.
  • Existing literature provides diagnostic techniques and identifies mimics of pediatric RLS.
  • Comorbidities like ADHD, depression, and anxiety are frequently associated with pediatric RLS.

Purpose of the Study:

  • To review recent advances in the understanding and management of pediatric RLS.
  • To discuss the role of iron deficiency and genetic factors in pediatric RLS.
  • To highlight the need for evidence-based therapeutic interventions.

Main Methods:

  • Literature review of existing studies on pediatric RLS.
  • Analysis of diagnostic criteria and management strategies.
  • Examination of comorbidity, genetic associations, and therapeutic outcomes.

Main Results:

  • Iron deficiency is implicated, with iron therapy showing symptom reduction.
  • Five genetic variants are linked to RLS, particularly in familial early-onset cases.
  • Medications show promise in case reports, but placebo-controlled trials are lacking.

Conclusions:

  • Pediatric RLS is a significant condition with complex contributing factors.
  • Iron supplementation may benefit patients with relative iron deficiency.
  • Further high-quality research, including double-blind, placebo-controlled trials, is essential for optimizing pediatric RLS treatment.

More Related Videos

Home-Based Monitor for Gait and Activity Analysis07:24

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Related Concept Videos

Restless Leg Syndrome and Night Terrors01:27

Restless Leg Syndrome and Night Terrors

Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...